WAYNE, PA — Cagent Vascular, Inc. has announced the launch of its latest innovation, the Serranator SL-PRO™ PTA Serration ...

Cagent Vascular Chairman and CEO Brian Walsh added ... The Serranator ® and Serranator SL-PRO™ PTA Serration Balloon Catheters are FDA-cleared, novel balloons using proprietary stainless ...

Cagent Initiates POINT FORCE Registry of Serranator PTA Catheter January 28, 2025—Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, ...

Vascular. 2007;15(1):5-11. According to Ballard and colleagues, factors such as female sex, superficial femoral artery occlusion, perioperative vascular complications, and hypercholesterolemia ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

These two categories also determine whether or not a drug stays in one area of the body (local effect) or is absorbed by the vascular system to be distributed to body tissues (systemic effect). This ...